StockIQStockIQ.tech
Account
Register Login

Labcorp Holdings Inc. (LH) Stock Analysis

--

Free AI-powered analysis and research for Labcorp Holdings Inc. stock

Sector: Healthcare

LH snapshot

Data as of 9 Oct 2026 close. Updated daily.

Last close
312.15 USD (-0.65%)
52-week range
244.52 – 341.80
Position in range
70%
1-year change
+12.3%
Market cap (USD)
$25.3B
P/E (trailing)
25.7
RSI (14-day)
39
vs 200-day average
+10.8%
MACD
Above signal line
StockIQ score: 57/100 · Mixed signals

Labcorp Holdings Inc. scores 57/100 on StockIQ's model, which reads as mixed signals overall. The price is above its 200-day average and at 70% of its 52-week range, up 12.3% over the past year. Latest reported figures show a profit margin of 7.0%, return on equity of 11.7% and revenue growth of +5.8%.

What is driving the score
  • Strong Downtrend: -12
  • MACD Bullish: +8
  • Strong Long-term Uptrend: +8
  • Positive YTD (+12.3%): +3

Automated, general information only – not financial advice. Scores can be wrong. How the score works

Full LH report

Labcorp Holdings Inc. (LH) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze LH Now →

📰 Latest Update

Labcorp (LH): Is Its Earnings Discount Worth the Growing Investment Bill?

Labcorp (LH) is facing scrutiny as its earnings appear discounted amid rising investment costs. This situation raises concerns for investors regarding the company's ability to balance growth initiatives with profitability. As Labcorp continues to invest heavily in expanding its capabilities, stakeholders should assess whether the potential long-term benefits justify the current valuation and associated risks.

Read full article →

History

People also watch

MRK
Merck & Co. Inc.
--
ABT
Abbott Laboratories
--
CVS
CVS Health Corporation
--
MLYS
Mineralys Therapeutics, Inc.
--
WRBY
Warby Parker Inc.
--